Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
Research output: Contribution to journal › Journal article › Research › peer-review
Low-dose treatment with acetylsalicylic acid (ASA) is widely recommended to type 2 diabetic patients as primary prevention against cardiovascular disease. High-dose treatment with cyclooxygenase inhibitors reduces urinary albumin excretion rate (AER) in type 1 diabetic patients with micro- or macroalbuminuria. Whether a similar effect on AER exists during low-dose ASA treatment, which may confound the diagnosis and monitoring of micro- and macroalbuminuria in type 2 diabetic patients, remains to be elucidated.
| Original language | English |
|---|---|
| Journal | Nephrology, Dialysis, Transplantation |
| Volume | 18 |
| Issue number | 3 |
| Pages (from-to) | 539-42 |
| Number of pages | 4 |
| ISSN | 0931-0509 |
| Publication status | Published - 2003 |
- Adult, Aged, Albuminuria, Aspirin, Cardiovascular Diseases, Cross-Over Studies, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Female, Fibrinolytic Agents, Glomerular Filtration Rate, Hemodynamics, Humans, Kidney, Male, Middle Aged, Time Factors
Research areas
ID: 38454742